
Yunsoo Kim
Examiner (ID: 7199)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 1252 |
| Issued Applications | 623 |
| Pending Applications | 162 |
| Abandoned Applications | 507 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20287204
[patent_doc_number] => 20250312447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY
[patent_app_type] => utility
[patent_app_number] => 19/248893
[patent_app_country] => US
[patent_app_date] => 2025-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19248893
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/248893 | METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY | Jun 24, 2025 | Pending |
Array
(
[id] => 20193632
[patent_doc_number] => 20250270342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
[patent_app_type] => utility
[patent_app_number] => 19/198946
[patent_app_country] => US
[patent_app_date] => 2025-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19198946
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/198946 | Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses | May 4, 2025 | Pending |
Array
(
[id] => 20193632
[patent_doc_number] => 20250270342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
[patent_app_type] => utility
[patent_app_number] => 19/198946
[patent_app_country] => US
[patent_app_date] => 2025-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19198946
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/198946 | Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses | May 4, 2025 | Pending |
Array
(
[id] => 20219924
[patent_doc_number] => 20250282855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA)
[patent_app_type] => utility
[patent_app_number] => 19/070188
[patent_app_country] => US
[patent_app_date] => 2025-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19070188
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/070188 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA) | Mar 3, 2025 | Pending |
Array
(
[id] => 20048199
[patent_doc_number] => 20250186421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => METHODS OF TREATING INFLAMMATORY AND/OR ALLERGIC DISORDERS WITH NORKETOTIFEN
[patent_app_type] => utility
[patent_app_number] => 19/061157
[patent_app_country] => US
[patent_app_date] => 2025-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19061157
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/061157 | METHODS OF TREATING INFLAMMATORY AND/OR ALLERGIC DISORDERS WITH NORKETOTIFEN | Feb 23, 2025 | Pending |
Array
(
[id] => 20100295
[patent_doc_number] => 20250230231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => Production of Biosimilar Ustekinumab In CHO Cells
[patent_app_type] => utility
[patent_app_number] => 19/048808
[patent_app_country] => US
[patent_app_date] => 2025-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19048808
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/048808 | Production of Biosimilar Ustekinumab In CHO Cells | Feb 6, 2025 | Pending |
Array
(
[id] => 20032023
[patent_doc_number] => 20250170245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => STABLE, AQUEOUS FORMULATIONS OF ANTIBODIES THAT BIND IL5 RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 19/045166
[patent_app_country] => US
[patent_app_date] => 2025-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19045166
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/045166 | STABLE, AQUEOUS FORMULATIONS OF ANTIBODIES THAT BIND IL5 RECEPTOR | Feb 3, 2025 | Pending |
Array
(
[id] => 19989645
[patent_doc_number] => 20250127867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => METHOD OF TREATING PRECLINICIAL ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/926209
[patent_app_country] => US
[patent_app_date] => 2024-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18926209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/926209 | METHOD OF TREATING PRECLINICIAL ALZHEIMER'S DISEASE | Oct 23, 2024 | Pending |
Array
(
[id] => 19722674
[patent_doc_number] => 20250025425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => Particle Formation And Morphology
[patent_app_type] => utility
[patent_app_number] => 18/907018
[patent_app_country] => US
[patent_app_date] => 2024-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18907018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/907018 | Particle Formation And Morphology | Oct 3, 2024 | Pending |
Array
(
[id] => 19722674
[patent_doc_number] => 20250025425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => Particle Formation And Morphology
[patent_app_type] => utility
[patent_app_number] => 18/907018
[patent_app_country] => US
[patent_app_date] => 2024-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18907018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/907018 | Particle Formation And Morphology | Oct 3, 2024 | Pending |
Array
(
[id] => 19692872
[patent_doc_number] => 20250011417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/888320
[patent_app_country] => US
[patent_app_date] => 2024-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18888320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/888320 | METHODS FOR THE TREATMENT OF THYROID EYE DISEASE | Sep 17, 2024 | Pending |
Array
(
[id] => 19692872
[patent_doc_number] => 20250011417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/888320
[patent_app_country] => US
[patent_app_date] => 2024-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18888320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/888320 | METHODS FOR THE TREATMENT OF THYROID EYE DISEASE | Sep 17, 2024 | Pending |
Array
(
[id] => 19614982
[patent_doc_number] => 20240400662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/774646
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774646 | Compositions and methods for treating synucleinopathies | Jul 15, 2024 | Issued |
Array
(
[id] => 19614981
[patent_doc_number] => 20240400661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/774629
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774629
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774629 | Compositions and methods for treating synucleinopathies | Jul 15, 2024 | Issued |
Array
(
[id] => 19614981
[patent_doc_number] => 20240400661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/774629
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774629
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774629 | Compositions and methods for treating synucleinopathies | Jul 15, 2024 | Issued |
Array
(
[id] => 19614982
[patent_doc_number] => 20240400662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/774646
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774646 | Compositions and methods for treating synucleinopathies | Jul 15, 2024 | Issued |
Array
(
[id] => 19614980
[patent_doc_number] => 20240400660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/774608
[patent_app_country] => US
[patent_app_date] => 2024-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774608
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/774608 | Compositions and methods for treating synucleinopathies | Jul 15, 2024 | Issued |
Array
(
[id] => 19380994
[patent_doc_number] => 20240270864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => COMPOSITIONS AND METHODS FOR INJECTING PARTICLE SUSPENSIONS
[patent_app_type] => utility
[patent_app_number] => 18/633795
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18633795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/633795 | COMPOSITIONS AND METHODS FOR INJECTING PARTICLE SUSPENSIONS | Apr 11, 2024 | Pending |
Array
(
[id] => 19380994
[patent_doc_number] => 20240270864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => COMPOSITIONS AND METHODS FOR INJECTING PARTICLE SUSPENSIONS
[patent_app_type] => utility
[patent_app_number] => 18/633795
[patent_app_country] => US
[patent_app_date] => 2024-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18633795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/633795 | COMPOSITIONS AND METHODS FOR INJECTING PARTICLE SUSPENSIONS | Apr 11, 2024 | Pending |
Array
(
[id] => 19345197
[patent_doc_number] => 20240254160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => SEPARATION OF PRE-PEAK AND POST-PEAK IN FUSION PROTEIN SAMPLE BY USING SIZE EXCLUSION HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 18/629465
[patent_app_country] => US
[patent_app_date] => 2024-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629465
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/629465 | SEPARATION OF PRE-PEAK AND POST-PEAK IN FUSION PROTEIN SAMPLE BY USING SIZE EXCLUSION HIGH PERFORMANCE LIQUID CHROMATOGRAPHY | Apr 7, 2024 | Pending |